ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 48 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,000 | -42.9% | 1,575 | -51.2% | 0.00% | – |
| Q3 2019 | $7,000 | -36.4% | 3,225 | -18.7% | 0.00% | – |
| Q2 2019 | $11,000 | -84.3% | 3,967 | -80.3% | 0.00% | -100.0% |
| Q1 2019 | $70,000 | +27.3% | 20,159 | -15.3% | 0.00% | 0.0% |
| Q4 2018 | $55,000 | +400.0% | 23,803 | +800.3% | 0.00% | – |
| Q3 2018 | $11,000 | +57.1% | 2,644 | +19.6% | 0.00% | – |
| Q2 2018 | $7,000 | +40.0% | 2,210 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 2,210 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -95.1% | 2,210 | -87.5% | 0.00% | -100.0% |
| Q3 2017 | $81,000 | +1925.0% | 17,643 | +931.2% | 0.00% | – |
| Q2 2017 | $4,000 | -98.9% | 1,711 | -98.5% | 0.00% | -100.0% |
| Q1 2017 | $371,000 | +16.3% | 117,657 | -4.0% | 0.01% | 0.0% |
| Q4 2016 | $319,000 | -37.8% | 122,544 | -7.2% | 0.01% | -41.7% |
| Q3 2016 | $513,000 | +44.5% | 131,992 | -0.0% | 0.01% | +33.3% |
| Q2 2016 | $355,000 | – | 132,004 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |